Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ara Klijian

Thoracic Surgery (Cardiothoracic Vascular Surgery) Murrieta, CA Medical Doctor

NPI 1831134162 CMS profile 83265

28078 Baxter Rd, Murrieta, CA 92563

Open in the dashboard

General payments

$916,073

901 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ara Klijian of Murrieta, CA is reported in the CMS Open Payments database as having received $916,073 across 901 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $143,815 147
2024 General $112,404 109
2023 General $83,901 73
2022 General $113,333 88
2021 General $126,710 127
2020 General $61,075 74
2019 General $274,835 283

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ara Klijian
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Ara Klijian were reported at $143,815. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Ara Klijian Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $274,835 $886 $178–$3,167 $163
2020 $61,075 $341 $108–$1,605 $114
2021 $126,710 $453 $125–$1,886 $132
2022 $113,333 $695 $180–$2,566 $149
2023 $83,901 $745 $205–$2,662 $160
2024 $112,404 $799 $214–$2,967 $164
2025 $143,815 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Davol Inc. $408,296 376 payments
  2. La Jolla Pharmaceutical Company $399,447 324 payments
  3. Mallinckrodt Enterprises LLC $44,803 46 payments
  4. Acacia Pharma Inc $16,561 23 payments
  5. Eagle Pharmaceuticals, Inc. $15,814 13 payments
  6. BTG International, Inc. $12,362 6 payments
  7. Mallinckrodt Hospital Products Inc. $8,463 7 payments
  8. AstraZeneca Pharmaceuticals LP $1,286 11 payments
  9. Becton, Dickinson and Company $1,046 9 payments
  10. On Target Laboratories, Inc $657 16 payments
  11. Other $7,339 70 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Honoraria $552,585 127 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $143,701 27 payments
  3. Travel and Lodging $100,377 367 payments
  4. Consulting Fee $65,407 11 payments
  5. Food and Beverage $29,021 363 payments
  6. Education $24,982 6 payments
Products named General payments · program years 2019–2025
  1. GIAPREZA Emergent Hypotension $236,754 173 payments
  2. GIAPREZA Giapreza $162,693 151 payments
  3. OFIRMEV $53,267 53 payments
  4. BARHEMSYS Post Operative Nausea and Vomiting $18,914 15 payments
  5. ARISTA AH FlexiTip Surgery $18,246 53 payments
  6. ARISTA $15,585 54 payments
  7. BARHEMSYS PONV postoperative nausea vomiting $13,438 20 payments
  8. PROGEL $5,616 47 payments
  9. ARISTA AH $5,000 1 payment
  10. ARISTA AH FLEXITIP BD Interventional Surgery $4,724 18 payments
  11. Other $17,554 149 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

12

Median for Thoracic Surgery: 42

Drug cost

$128

Median for Thoracic Surgery: $318

Branded share of claims

100%

Median for Thoracic Surgery: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Acetaminophen-Codeine Acetaminophen With Codeine Brand 12 $128

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 910 Part D prescribers listed as Thoracic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 28 billing codes

Paid by Medicare

$145,290

Medicare's payments for the services billed

Medicare patients

40

Average age 73

Services billed

346

20 women, 20 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
COPD 68%
Ischemic heart disease 65%
Cancer 60%
Diabetes 58%
Heart failure 55%
Arthritis 55%
Chronic kidney disease 48%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
AIRSUPRA
  • AstraZeneca Pharmaceuticals LP $123
$123 — —
KEYTRUDA
  • Merck Sharp & Dohme Corporation $115
$115 — —
XARELTO
  • Janssen Pharmaceuticals, Inc $24
$24 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

901 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record